Unique ID issued by UMIN | UMIN000020535 |
---|---|
Receipt number | R000023711 |
Scientific Title | A Phase II study of robot-assisted colorectal cancer surgery |
Date of disclosure of the study information | 2016/01/12 |
Last modified on | 2016/01/12 18:18:03 |
A Phase II study of robot-assisted colorectal cancer surgery
robot-assisted colorectal cancer surgery study
A Phase II study of robot-assisted colorectal cancer surgery
robot-assisted colorectal cancer surgery study
Japan |
colorectal cancer
Gastrointestinal surgery |
Malignancy
NO
The objective of this study was to explore the safety and efficacy of obot-assisted colorectal cancer surgery with da Vinci surgical system
Safety,Efficacy
Exploratory
Phase II
Grade 3 or higher surgical complications (Clavien-Dindo Classification)
Grade 2 or higher surgical complications (Clavien-Dindo Classification), medical care cost, obot-assisted colorectal cancer surgery completion rate, With or without conversion from obot-assisted surgery to open surgery, adverse event during surgery, performance of surgery, early postoperative course, surgery-related death, relapse free survival
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
obot-assisted colorectal cancer surgery with lymph node dissection
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1) Histologically confirmed Rectum adenocarcinoma
2) Without liver, peritoneum and distant metastases
3)Age of 20-80 years
4) without prior anti-tumor therapy (radiation therapy, chemotherapy and hormone therapy)
5)Aadequate function of important organs
1. WBC: >=3, 000/mm3 and 12,000/mm3
2. Neutrophil: >=1,500/mm3
3. Platelet: >=100,000/mm3
4. Hemoglobin: >=9.0g/dL
5. AST, ALT: <100IU/L
6. T Bil: <=2.0mg/dL
7. Serum creatinine: <=1.2mg.DL
6) ECG: without clinically problematic abnormalities within 28 days before registration
7) Eastern Cooperative Oncology Group performance status (PS) 0-1
8) With ability of oral intake
9) Written informed concent
1) had serious complication (e.g. interstitialpneumonia, or pulmonary fibrosis, kidney injury, hepatic failure, uncontrolled diabetes mellitus, uncontrolled hypertension)
2) with active double cancer
3) had active infection disease (over 38.0 degree)
4) with psychosis or psychological symptom
5) Physician will determine that the patient is inappropriate participate in this trail for the safety.
15
1st name | |
Middle name | |
Last name | Hajime Morohashi |
Hirosaki University Hospital
Hirosaki University Hospital
Hontyo53, Hiroski City, Aomori Pref.
0172-33-5111
hm2002@hirosaki-u.ac.jp
1st name | |
Middle name | |
Last name | Hajime Morohashi |
Hirosaki University Hospital
Hirosaki University Hospital
Hontyo53, Hiroski City, Aomori Pref.
0172-33-5111
hm2002@hirosaki-u.ac.jp
Hirosaki University Hospital
non
Self funding
NO
2016 | Year | 01 | Month | 12 | Day |
Unpublished
Open public recruiting
2016 | Year | 01 | Month | 12 | Day |
2016 | Year | 01 | Month | 18 | Day |
2016 | Year | 01 | Month | 12 | Day |
2016 | Year | 01 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023711